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WE RECENTLY noted that the inherent
incidence of spontaneous lymphomata in
the AKR mouse strain was markedly
reduced by ovum fusion to the CBA/H-
T6T6 strain (Barnes, Tuffrey and King-
man, 1972a). Whereas lymphomata were
invariable in the AKR strain, tumours
were seen only in a third of ovum fusion-
derived AKR +-+ CBA/H-T6T6 tetra-
parental chimaeras (Barnes, Tuffrey and
Ford, 1973). The tumour resistance of
these chimaeras was particularly sur-
prising since, in spite of roughly balanced
coat colour composition and distribution
ofthe gametes, cytogenetic analysis ofthe
peripheral blood samples showed an over-
whelming predominance (average >95%)
of lymphoma-prone AKR lymphoid cells
(Tuffrey et al., 1973). This predominance
of AKR cells was not only seen in the
peripheral blood, but was also noted in
analysis of both the lymphomyeloid com-
plex and the somatic tissues of all these
chimaeras (Ford et al., unpublished). In
spite ofthis, the AKR associated lympho-
mata appeared to have been in some way
inhibited by relatively few CBA cells
present in the chimaeras. One possible
argument against this view was the
possibility of maternal influence. After
fusion of the AKR and CBA morulae,
which had been cultured in vitro to the
blastocyst stage, the embryo was then
transplanted into a pseudopregnant recipi-
ent. In the case of the AKR<-* CBA/H-
T6T6 chimaeras, this was invariably a
CBA/I-T6T6 recipient which was also
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used to milk foster the chimaeras. It is
possible that maternal advantage may
have been conferred upon the foetus at a
stage beyond implantation. To exclude
this unlikely possibility, the incidence of
tumours has been investigated in a group
of ovum-transplated AKR mice born and
milk-fostered from the CBA/H-T6T6
strain.
MATERIALS AND METHODS
The CBA mutant, CBA/H-T6T6, together
with inbred AKR mice, were used for this
study. AKR embryos were obtained at the
blastocyst stage andtransplantedintopseudo-
pregnant CBA recipients by the technique
which is described in detail elsewhere (Barnes
et al., 1972b). The ovum transplantation-
derived AKR progeny were subsequently
milkfed bythe same CBA/H-T6T6recipients.
Normally derived AKR and CBA/H-T6T6
controls were housed in the same animal
rooms and these, together with the experi-
mental groups, were examined clinically at
weekly intervals for evidence of lymphoma.
The mice were sacrificed on evidence of
declining health with either marked dyspnoea
or gross lymphadenopathy, and examined
post mortem for the presence ofa lymphoma.
In cases where there was any doubt, sections
oflymph node/thymus were prepared, stained
with haematoxylin and eosin, and examined
histologically.
RESULTS
As can be seen from Fig. 1, there was
a 100% incidence of lymphomata in
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FiG. 1. Incidence of lymphomata in both normally derived AKR mice and those born following ovum
transplantation from CBA/H-T6T6.
Seven AKR controls, found dead or
sacrificed due to other factors, but where
no tumours were found, were excluded
from the series. The majority of the
53 CBA/H-T6T6 controls lived for more
than 56 weeks without evidence of a
tumour. The exception was one male
which was found to have a hepatoma at
46 weeks of age. Further details of the
findings in this control group will be
published elsewhere.
In spite of transplanting more than
300 blastocysts, only 53 AKR mice
survived weaning (Fig. 1). Cannibalism in
the immediate postnatal period appeared
the most common single cause of neonate
loss. In spite of the limited number of
ovum transplanted AKR mice available
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for investigation, it is quite clear from
Fig. 1 that these all developed lympho-
mata and at a time comparable with the
normally derived AKR controls. It is
quite obvious that ovum transplantation
(and milk fostering) fromtheCBA/H-T6T6
has not influenced the innate tumour
susceptibility ofthe AKR.
DISCUSSION
Fekete and Otis (1954) were the first
to use ovum transplantation to study
tumour susceptibility. They showed that
the incidence of lymphomata was un-
altered in AKR transplanted into, and
born from, C3H recipients. In recent
years it has become quite apparent that
polygenetic factors influence tumour sus-
ceptibility in mice (for review see Lilley
and Pincus, 1973) and it was conceivable
that the results of Fekete and Otis' (1954)
work may have been different if another
recipient strain had been used. However,
this does not appear to be the case since
our findings using the CBA recipients are
very similar. Both results suggest that
the cause of the lymphoma in the AKR
strain is established before the stage of
implantation, and subsequent maternal
influence is of no consequence in the
context of tumour susceptibility.
Our major reason for repeating Fekete
and Otis' (1954) experiment using CBA
recipients was to exclude the possibility
of maternal (CBA) influence being respon-
sible for tumour resistance of the ovum-
fusion derived AKR - CBA chimaeras
(Barnes et al., 1973).
As mentioned earlier, ovum fusion was
followed by transplantation and develop-
ment from a pseudopregnant recipient.
In the case ofthe AKR - CBA chimaeras
the recipient was invariably CBA. Con-
ceivably maternal advantage at or beyond
the stage of implantation may have
contributed to the apparent tumour
resistance ofthese chimaeras. The results
here suggest that any such maternal
influence has no effect upon the tumour
susceptibility of the AKR and the same
assumption seems very likely for the
AKR-CBA chimaeras.
REFERENCES
BARNES, R. D., Tl,FFREY, M. & FORD, C. E. (1973)
Suppression of Lymphoma Development in
Tetraparental AKR Mouse Chimaeras Derived
from Ovum Fusion. Nature, New Biol., 244, 282.
BARNES, R. D., TUFFREY, M. & KINGMAN, J. (1972a)
The Delay of Leukaemia in Tetraparental Ovum
Fusion-derived AKR Chimaeras. Clin. & exp.
Immunol., 12, 541.
BARNES, R. D., TIJFFREY, M., KINGMAN, J. &
RISDoN R. A. (1972b) The Disease of the NZB
Mouse. Examination of Exchange Ovum
Transplantation Derived NZB and CFW Mice.
Clin. & exp. Immunol., 10, 493.
FEKETE, E. & OTIS, H. K. (1954) Observations on
Leukemia in AKR Mice Born from Transferred
Ova and Nursed by Low Leukemic Mothers.
Cancer Res., 14, 445.
LILLEY, F. & PINCUS, T. (1973) Genetic Control of
Murine Viral Leukemogenesis. Adv. Cancer Res.,
17, 231.
TITFFREY, M., BARNES, R. D., EVANS, E. P. &
FORD, C. E. (1973) Dominance of AKR Lympho-
cytes in Tetraparental AKR +-+ CBA-T6T6
Chimaeras. Nature, New Biol., 243, 207.